KT Medical Service Public Company LimitedSET: KTMS🇹🇭 TH

Internal Control · 2025

Internal Control — Board Opinion

Introduction

The company places importance on establishing a robust internal control system, which is a key factor in supporting efficient business operations. The company has implemented an internal control system that is adequate, effective, covers all aspects of the company's operations, and complies with relevant laws, regulations, and rules. Furthermore, the company has established sufficient and effective check-and-balance mechanisms, including clear authorization limits and operational procedures. The scope of duties and responsibilities for executives and employees in each department are defined to ensure mutual checks and balances. The company has also appointed an external independent internal auditor, Proud Advisory Co., Ltd., to audit the operations of various departments within the Group to ensure compliance with established policies and regulations, and to report audit results directly to the Audit Committee. Ms. Wipada Sattha has been appointed as the Head of Internal Audit, responsible for internal auditing, compliance auditing according to the internal audit plan, coordinating and monitoring the implementation of resolutions from Audit Committee meetings, analyzing and assessing the adequacy of the internal control system, and providing effective recommendations to auditees, as well as overseeing the interests of all stakeholders. Additionally, EY Office Limited, the certified public accountant for the company and its subsidiaries, has reviewed the internal controls of the company and its subsidiaries related to the preparation and presentation of financial statements to ensure the appropriateness and reliability of financial reports. No material deficiencies were found that could significantly impact the auditor's opinion on the financial statements of the company and its subsidiaries for the period from January 1, 2025, to December 31, 2025.

The Board of Directors' meeting assessed the adequacy of the company's internal control system using the SEC's assessment form. The assessment covered five components of the internal control system, namely:

  1. Control Environment

  2. Risk Assessment

  3. Control Activities

  4. Information & Communication System

  5. Monitoring Activities

The Board of Directors is of the opinion that the Group's internal control system is adequate and appropriate, with all components being effectively implemented. This includes consistent adherence to generally accepted accounting standards, announcements from the Securities and Exchange Commission (SEC), and regulations of the Stock Exchange of Thailand in the company's quarterly and annual financial statements, as required. Furthermore, there are processes for preparing and disclosing financial statement information accurately, completely, sufficiently, and in a timely manner. The internal control system is adequate and appropriate, and it is efficiently updated and revised to align with changing circumstances, ensuring that the company's operations achieve their stated objectives and comply with relevant laws and regulations. No material issues or deficiencies have been found that could cause damage to the company's operations. Additionally, there is an adequate internal control system in place for transactions with major shareholders, directors, executives, or related parties, and the Audit Committee does not hold a different opinion from that of the Board of Directors.

Summary of the Board's Opinion on Internal Control

Proud Advisory Co., Ltd., as an independent internal auditor appointed by the company to evaluate, audit, and monitor the improvement of the adequacy and effectiveness of the internal control systems of the company and its subsidiaries, has conducted risk assessments, prepared annual internal audit plans, performed audits, monitored system improvements, and reported directly to the Audit Committee quarterly. The primary objectives are to assess the efficiency and adequacy of the current internal control systems, compliance with relevant policies and procedures, and the appropriateness and reliability of the financial reports of the company and its subsidiaries.

At the Annual Board of Directors Meeting for 2025, attended by all three Audit Committee members, the Board of Directors assessed the adequacy of the internal control systems of the company and its subsidiaries. After questioning management, it was concluded that, based on the evaluation of internal control systems according to the guidelines of The Committee of Sponsoring Organizations of Treadway Commission ("COSO") and using the internal control system adequacy assessment form from the Securities and Exchange Commission (SEC), which comprises the following five components:

1) Control Environment

2) Risk Assessment

3) Control Activities

4) Information & Communication

5) Monitoring Activities


The Board of Directors is of the opinion that the company has established management and internal control systems across five areas in accordance with the COSO framework. Overall, these systems are comprehensive, in good standing, adequate, and appropriate for the size of the business and current circumstances. Management has encouraged employees within the organization to recognize the importance of internal controls and has ensured sufficient and suitable personnel are in place to enable the company's operations to meet its objectives, comply with relevant laws and regulations, and adhere to good corporate governance principles. The company has clearly defined duties and responsibilities, and has established appropriate written rules, regulations, policies, and operational approval authorities.


Furthermore, the company has established an independent internal audit function to monitor and evaluate internal controls by engaging an external internal auditor (Outsource) to review the internal control systems. This auditor reports directly to the Audit Committee. The adequacy assessment form for the company's internal control system for 2025 has been considered and approved, and will be reported at the Audit Committee and Board of Directors meetings within the first quarter of 2026.

Adequacy & Appropriateness of the Internal Control System

Internal Control Framework Used

FrameworkDetail
The Committee of Sponsoring Organizations of the Treadway Commission (COSO)

Having a good internal control system is crucial for ensuring that the company can achieve its objectives, as it also helps manage risks and reduce various damages from incidents that may occur to the company and its stakeholders. Therefore, the company has established an Audit Committee and a Corporate Governance and Social Responsibility Working Group, which can perform their duties efficiently and independently, to review the internal control system for maximum effectiveness. The company's internal control system covers 5 main topics, in accordance with the principles of the Committee of Sponsoring Organizations of the Treadway Commission (COSO), using the internal control system adequacy assessment form from the Securities and Exchange Commission (SEC), which consists of the following 5 components:

1) Control Environment

2) Risk Assessment

3) Control Activities

4) Information & Communication System (Information & Communication)

5) Monitoring Activities

Internal Control Deficiencies

Number of Deficiencies

MetricCurrent YearPrevious YearTwo Years Ago
Total number of internal control system deficiencies (cases)000

Audit Committee & Auditor Observations

Audit Committee's Opinion Differs from the Board's

No

Auditor Has Observations on Internal Control

No

Opinion on the Head of Internal Audit

Head of Internal Audit

3160

Audit Committee's Opinion on the Head of Internal Audit

In 2025, the Audit Committee meeting appointed Proud Advisory Co., Ltd. to serve as the internal auditor for the Group of Companies, with Mr. Parit Buapuean as the Head of Internal Audit and Operations Controller (the qualifications of the Head of Internal Audit are detailed in Attachment 3, "Details of the Head of Internal Audit"). Mr. Buapuean will be primarily responsible for performing the internal audit duties of the Group of Companies. The Board of Directors has considered the qualifications of Proud Advisory Co., Ltd. and Mr. Parit Buapuean and deemed them sufficiently suitable for the aforementioned duties, owing to their independence, experience in internal audit operations, and completion of relevant training courses in internal audit operations.

Appointment, Discharge & Transfer of the Head of Internal Audit

Requires Audit Committee Approval

Yes

Description

Furthermore, the consideration and approval for the appointment, removal, or transfer of the individual holding the position of Head of the Company's Internal Audit Unit must receive approval from the Audit Committee. The qualifications for the Head of Internal Audit are detailed in Annex 3.

Related Party Transactions

Introduction

The company prioritizes conducting business with transparency and considering all stakeholders. Therefore, the company has clearly established policies and procedures for related party transactions to serve as guidelines for entering into such transactions. This ensures that all related party transactions are conducted transparently, without conflicts of interest, are approved by management, the Board of Directors, or the shareholders' meeting, and are accurately and completely disclosed. This is primarily for the utmost benefit of the company and its shareholders. The intercompany transactions between the company and its related entities that have occurred recently are normal business transactions, with various terms and conditions for these transactions established to be in accordance with normal commercial terms and market prices, and are conducted in the same manner as with unrelated parties of a similar or comparable nature.

Has Related Party Transactions

Yes

Counterparties & Transactions

Monetary Unit

1

Counterparties with Potential Conflicts

NamePerson / Juristic PersonType of BusinessNature of RelationshipAs of Date (YYYY-MM-DD)
Filter Vision Public Company LimitedJuristic PersonImport and distribute various products and equipment related to water purification systems. Design, assemble, and install water treatment systems. Upgrade, repair, and maintain various products and equipment to ensure continuous operation for clients in the restaurant, beverage, and residential sectors.

Holds a 53.08% stake in the company

2025-12-31T00:00
Innovatech (Asia) Company LimitedJuristic PersonProvide consultation, design, equipment sales, installation, and maintenance services for water production and clean energy system solutions, with a focus on ESG (Environmental, Social, Governance) principles. These services are offered to various public and private organizations that are interested in ESG matters or are impacted by environmental policies.

is a subsidiary of Filter Vision Public Company Limited

2025-12-31T00:00
Dr. Vichit TechakasemPerson

Director / Authorized Signatory of the Company / is a shareholder of KT Medical Services Public Company Limited, Irving Corporation Company Limited, Medical Vision Company Limited, and Nephro Vision Company Limited, and is the husband of Ms. Kanjana Pongpatanadecha.

2025-12-31T00:00

Transactions by Counterparty

Transactions
2773.62 · Necessity: KT Medical Services Public Company Limited charges service fees to Filter Vision Public Company Limited for the service and the right to use the cloud server system for asset management software. The aforementioned price is calculated at the same rate as the service fees of service providers in the industry and is based on actual usage allocation. · Description: Revenue from service fees and licensing for asset management software on cloud servers · As of yesteryear: 0.0 · Nature of transaction: KT Medical Services Public Company Limited: Service Revenue Items · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 0.0 · 74000.0 · Necessity: KT Medical Services Public Company Limited has purchased assets from Filter Vision Public Company Limited. The Company has compared the purchase price of these assets with other vendors in accordance with its procurement process. · Description: Acquisition of assets, comprising Water Logic water dispensers, one unit for each of the Nakhon Mae Sot branch, Chom Thong branch, Somdet Phra Sangkharat (Tha Muang) branch, and the Head Office. · As of yesteryear: 99025.0 · Nature of transaction: KT Medical Services Public Company Limited: Asset Acquisition · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 19855840.0 · 841521.42 · Necessity: 1. KT Medical Services Public Company Limited has expenses for photocopying, document delivery fees, and repair costs, which are charged by Filter Vision Public Company Limited. These service fees are based on actual usage. 2. KT Medical Services Public Company Limited has service fees for using the SAP system, service fees for using the T-Reg program, and system maintenance fees, which are charged by Filter Vision Public Company Limited. These service fees are calculated based on the allocation of actual expenses according to the number of active users. 3. The service fees for using the T-Reg program are in the form of advance payments for services according to the contract period to Filter Vision Public Company Limited. 4. KT Medical Services Public Company Limited has system maintenance fees, which are charged by Filter Vision Public Company Limited. These service fees are calculated by comparing them with market prices under similar service conditions. · Description: Photocopying fees, document delivery fees, repair fees, SAP system usage fees, T-Reg program usage fees, and system maintenance fees · As of yesteryear: 756839.69 · Nature of transaction: KT Medical Services Public Company Limited: Service Fee List · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 685254.08 · 678210.0 · Necessity: 1. KT Medical Services Public Company Limited has a rental agreement for office and warehouse space with Filter Vision Public Company Limited, with a monthly rent of 42,226.00 Baht. This rental rate is in accordance with market prices. 2. Regarding utility expenses, for which the company is responsible, a fixed monthly payment of 14,291.50 Baht is made, based on the electricity and water consumption rates of the previous year. · Description: Office and warehouse rental fees, and utility fees · As of yesteryear: 378194.16 · Nature of transaction: KT Medical Services Public Company Limited: Rental Expenses Items · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 372287.04 · 205089.4 · Necessity: 1. Irving Corporation Co., Ltd. sells products to Filter Vision Public Company Limited. The price of these products is lower than the Price List due to the following reasons: 1.1 It is a normal sale of products to FVC without any after-sales warranty. 1.2 It is a sale of long-stocked and obsolete water system equipment at cost price. The trade terms are the same as those applied to other customers. 2. Irving Corporation Co., Ltd. provides water analysis services to Filter Vision Public Company Limited (FVC) as FVC does not have a water analysis laboratory. The service fee is charged on a per-instance basis. · Description: Revenue from the sale of products, such as water treatment chemicals and flow switches, and revenue from water analysis services. · As of yesteryear: 307722.12 · Nature of transaction: Irving Corporation Limited: Revenue from Sales of Goods and Services · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 459875.85 · 3499562.5 · Necessity: Irving Corporation Co., Ltd. purchases goods from Filter Vision Public Company Limited. The company has compared the purchase price of these goods with other suppliers in accordance with its procurement process. · Description: Purchase products such as valves, filters, UV lamps, and pure salt, etc. · As of yesteryear: 4505540.2 · Nature of transaction: Irving Corporation Co., Ltd.: Purchase of Goods · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 8687433.0 · 0.0 · Necessity: In 2024, Irving Corporation Co., Ltd. purchased assets from Filter Vision Public Company Limited. The company had compared the purchase price of these assets with other vendors in accordance with its procurement process. In 2025, Irving Corporation Co., Ltd. had no additional asset purchase transactions from Filter Vision Public Company Limited. · Description: Acquisition of assets, comprising 1 unit of Water Logic water dispenser. · As of yesteryear: 35850.0 · Nature of transaction: Irving Corporation Limited: Asset Acquisition List · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 0.0 · 502129.55 · Necessity: 1. Irving Corporation Co., Ltd. incurred charges for photocopying and document delivery from Filter Vision Public Company Limited. These service fees are based on actual usage. 2. Irving Corporation Co., Ltd. incurred service fees for SAP system usage, T-Reg program usage, and system maintenance, charged by Filter Vision Public Company Limited. These service fees are calculated based on the actual cost allocation according to the number of active users. 3. The service fee for T-Reg program usage is an advance payment for services to Filter Vision Public Company Limited, based on the contract period. 4. Irving Corporation Co., Ltd. incurred system maintenance fees charged by Filter Vision Public Company Limited. These service fees are calculated by comparing them with market prices under similar service conditions. · Description: Photocopying expenses, postage and courier expenses, repair and maintenance expenses, service fees for SAP system utilization, service fees for T-Reg program utilization, and system maintenance fees · As of yesteryear: 506794.93 · Nature of transaction: Irving Corporation Limited: Service Fee List · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 591294.5 · 726711.24 · Necessity: 1. Irving Corporation Co., Ltd. has a rental agreement for office and warehouse space with Filter Vision Public Company Limited, with a monthly rent of 45,109.00 Baht. This rental rate is in accordance with market prices. 2. Regarding utility expenses, for which the company is responsible, these are a fixed monthly payment of 15,450.27 Baht, based on the previous year's electricity and water consumption rates. · Description: Office and warehouse rental fees, and utility fees · As of yesteryear: 453573.36 · Nature of transaction: Irving Corporation Co., Ltd.: List of Rental Fees · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 531625.39 · 153761.95 · Necessity: 1. Medical Vision Co., Ltd. incurred photocopying expenses charged by Filter Vision Public Company Limited. The service fee is based on actual usage. 2. Medical Vision Co., Ltd. incurred service fees for SAP system usage, T-Reg program usage, and system maintenance fees charged by Filter Vision Public Company Limited. The service fees are calculated based on the allocation of actual expenses according to the number of active users. 3. The service fee for T-Reg program usage is an advance payment for services to Filter Vision Public Company Limited, based on the contract period. 4. Medical Vision Co., Ltd. incurred system maintenance fees charged by Filter Vision Public Company Limited. The service fees are calculated by comparing them with market prices under similar service conditions. · Description: Photocopying fees, SAP system usage fees, T-Reg program usage fees, and system maintenance fees · As of yesteryear: 217132.17 · Nature of transaction: Medical Vision Company Limited: Service Fee List · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 219238.22 · 71463.12 · Necessity: 1. Medical Vision Co., Ltd. has a rental agreement for office and warehouse space with Filter Vision Public Company Limited, with a monthly rent of 5,569.00 Baht. This rental price is in accordance with market rates. 2. Regarding utility expenses, for which the company is responsible, these are a fixed monthly payment of 386.26 Baht, based on the previous year's electricity and water consumption rates. · Description: Office and warehouse rental fees, and utility fees · As of yesteryear: 73021.68 · Nature of transaction: Medical Vision Co., Ltd.: List of Rental Fees · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 79312.08 · 0.0 · Necessity: In 2024, Medical Vision Co., Ltd. incurred outsourcing expenses from Filter Vision Public Company Limited. These outsourcing fees were charged based on the working hours that employees of Filter Vision Public Company Limited performed for Medical Vision Co., Ltd. In 2025, Filter Vision Public Company Limited did not perform any work for Medical Vision Co., Ltd. · Description: Contract fee · As of yesteryear: 1319550.0 · Nature of transaction: Medical Vision Co., Ltd.: List of Contract Fees · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 1083280.0 · 0.0 · Necessity: In 2024, Nephro Vision Co., Ltd. purchased assets from Filter Vision Public Company Limited. The company had compared the purchase price of these assets with other vendors in accordance with its procurement process. For 2025, Nephro Vision Co., Ltd. did not make any additional asset purchases from Filter Vision Public Company Limited. · Description: Acquisition of assets, comprising one Water Logic water dispenser at the Pa Sang branch. · As of yesteryear: 35850.0 · Nature of transaction: Nephro Vision Co., Ltd.: Asset Purchase List · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 69350.0 · 182623.3 · Necessity: 1. Nephro Vision Co., Ltd. has service fees for using the SAP system, service fees for using the T-Reg program, and system maintenance fees, which are charged by Filter Vision Public Company Limited. These service fees are calculated based on the allocation of actual expenses according to the number of active users. 2. The service fees for using the T-Reg program are in the nature of advance payments for services according to the contract period to Filter Vision Public Company Limited. 3. Nephro Vision Co., Ltd. has system maintenance fees, which are charged by Filter Vision Public Company Limited. These service fees are calculated by comparing them with market prices under similar service conditions. · Description: Service fees for using the SAP system, service fees for using the T-Reg program, and system maintenance fees. · As of yesteryear: 106311.71 · Nature of transaction: Nephro Vision Company Limited: Service Fees List · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 21004.5
2168.68 · Necessity: KT Medical Services Public Company Limited invoices Innovatech (Asia) Company Limited for service fees and the right to use the cloud server system for asset management software. The pricing is calculated at a rate equivalent to that of other service providers in the industry and is based on actual usage allocation. · Description: Revenue from service fees and licensing for asset management software on cloud servers · As of yesteryear: 0.0 · Nature of transaction: KT Medical Services Public Company Limited: Service Revenue Items · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 0.0 · 6624.79 · Necessity: 1. Irving Corporation Co., Ltd. sells products to Innovatech (Asia) Co., Ltd., with the product selling price and trade terms being the same as those offered to other customers. 2. Regarding the water analysis services provided to Innovatech (Asia) Co., Ltd., because Innovatech (Asia) Co., Ltd. does not have a water analysis laboratory, the service fee is charged on a per-instance basis. · Description: Revenue from product sales, such as chlorine test tablets and pipe fittings, and revenue from water analysis services. · As of yesteryear: 3554.13 · Nature of transaction: Irving Corporation Limited: Revenue from Sales of Goods and Services · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 0.0 · 1836040.0 · Necessity: Irving Corporation Co., Ltd. purchased goods from Innovatech (Asia) Co., Ltd. The company has compared the purchase price of these goods with other suppliers in accordance with the procurement process. · Description: Purchase products such as membranes, filter cartridges, and water filter tanks, etc. · As of yesteryear: 57562.5 · Nature of transaction: Irving Corporation Limited: Purchase List · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 0.0 · 1589640.0 · Necessity: Medical Vision Co., Ltd. incurred service fees from Innovatech (Asia) Co., Ltd. These service fees are charged based on the working hours performed by Innovatech (Asia) Co., Ltd.'s employees for Medical Vision Co., Ltd. · Description: Contract fee · As of yesteryear: 0.0 · Nature of transaction: Medical Vision Co., Ltd.: List of Contract Fees · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 0.0
1000000.0 · Necessity: Irving Corporation Co., Ltd. has engaged Dr. Vichit Techakasem as a business consultant on a monthly retainer of 100,000.00 Baht, commencing from March 2025. This fee is in line with market rates for such services. · Description: Business Consulting Fee · As of yesteryear: 0.0 · Nature of transaction: Irving Corporation Co., Ltd.: Consulting Fees · Audit committee opinion: The transactions have been reviewed by the Audit Committee for the reasonableness of their prices and their execution. · As of year before yesteryear: 0.0

Policy & Future Trends

Introduction

In 2025, the Company and its subsidiaries had related party transactions with entities or individuals who may have conflicts of interest. Most of these transactions involved the sale and purchase of goods, business support, short-term property leases, and the provision of services. The management of these business transactions complied with the criteria stipulated by the Securities and Exchange Commission.

Necessity and reasonableness of the transactions.

The majority of related party transactions between the Company and its subsidiaries are transactions between the Company and entities related to the Company's business operations, which contribute to business agility and foster development and growth. Such transactions are conducted with the interests of stakeholders as a priority and are not undertaken to transfer the benefits of the public company to any related parties.

Measures and procedures for approving related party transactions.

To ensure that related party transactions or connected transactions that may involve conflicts of interest are conducted transparently and to protect the interests of stakeholders, the Company has clearly defined the approval process for related party transactions within its operational authority. Related party transactions are reported quarterly to the Audit Committee for review and submission to the Board of Directors for consideration. This practice complies with the criteria stipulated by the Securities and Exchange Commission.

Furthermore, the Board of Directors has reviewed the principles regarding commercial agreements with general conditions for related party transactions, under which the management is authorized to operate within the principles approved by the Board. This is to provide the management with a clear framework, establish reasonable conditions, generate benefits for the Company, and ensure that transactions are conducted as if with external parties, thereby promoting transparency and compliance with relevant legal criteria.

Policy, Measures & Approval Process

Measures or procedures for approving related party transactions.


In 2025, the Board of Directors reviewed the company's policies and procedures for related party transactions with individuals or entities that may have conflicts of interest, to ensure transparency in such transactions and to protect the company's interests. The summary is as follows:

Transactions between the company and directors, executives, related persons, connected persons, or their related parties ("persons who may have conflicts of interest") must be conducted under general commercial terms or be commercial agreements similar to those that a reasonable person would enter into with a general counterparty in the same situation, with commercial bargaining power free from the influence of their status as a director, executive, or related person (as the case may be), under reasonable and verifiable conditions, and without causing any transfer of benefits. The criteria for entering into such transactions are as follows:


Case 1: Related party transactions that are normal business transactions.

The Board of Directors has, in principle, approved the management to authorize connected transactions that are commercial agreements with general commercial terms between the company and its subsidiaries and directors, executives, major shareholders, or related persons, provided that such transactions have commercial terms similar to those that a reasonable person would enter into with a general counterparty in the same situation, with commercial bargaining power free from the influence of their status as a director, executive, or related person (as the case may be), and are commercial agreements approved by the Board of Directors or in accordance with principles already approved by the Board. The company shall prepare a summary report of such transactions for reporting at the Audit Committee meetings and Board of Directors meetings every quarter.


Case 2: Other related party transactions.

For other related party transactions that require approval by the Board of Directors meeting or the Shareholders' meeting, according to the criteria set by the Securities and Exchange Commission of Thailand, the Audit Committee shall consider and provide opinions on the necessity of entering into such transactions and the appropriateness of their prices. This involves evaluating whether the terms are consistent with normal market business practices, comparable to prices with third parties, fair, reasonable, and verifiable. In cases where the Audit Committee lacks expertise in considering potential related party transactions, the company shall engage independent experts, such as auditors or independent asset appraisers, to provide opinions on such transactions. Furthermore, the company's related party transactions with persons who may have conflicts of interest must undergo consideration by the Audit Committee and receive approval from the Board of Directors, with Audit Committee members present at the meeting. In such meetings, directors with a vested interest shall not have the right to vote, and their opinions shall be used to inform the decision-making of the Board of Directors or shareholders, as the case may be.

The Board of Directors shall ensure that the company complies with the Securities and Exchange Act, regulations, announcements, orders, or requirements of the Stock Exchange of Thailand, the Office of the Securities and Exchange Commission, the Securities and Exchange Commission, or the Capital Market Supervisory Board, including compliance with requirements regarding the disclosure of connected transactions and the acquisition or disposal of significant assets of the company. Furthermore, the company will disclose such related party transactions in the notes to the financial statements audited by the company's auditor, in Form 56-1 One Report, annual reports, or other information as required by the Stock Exchange of Thailand and relevant agencies.

Future Trends in Related Party Transactions

Future connected transactions will be conducted by the Company in compliance with the Securities and Exchange Act and the regulations, announcements, orders, or requirements of the Stock Exchange of Thailand. Parties with potential conflicts of interest or stakes in such connected transactions shall not have the right to vote on those transactions. Furthermore, such connected transactions must undergo consideration in accordance with the connected transaction policy, ensuring they are conducted under normal commercial terms and at market prices comparable to or referable to the pricing conditions the Company applies to third parties. Additionally, the necessity and appropriateness of the price for entering into connected transactions must be reviewed by the Audit Committee. However, if the Audit Committee lacks expertise in potential connected transactions, the Company will consider appointing an independent appraiser, a specialized independent expert, or the Company's auditor to provide an opinion on such connected transactions, enabling the Audit Committee to make decisions and provide recommendations to the Board of Directors or shareholders, as the case may be. Should the Company's ordinary shares be listed on the Stock Exchange of Thailand, the Company will disclose such connected transactions in its annual registration statement (Form 56-1 One Report) in accordance with the criteria and laws governing securities and stock exchanges, and the regulations, announcements, orders, or requirements of the Stock Exchange of Thailand.


The Company anticipates that normal business transactions or business support transactions of the Company and its subsidiaries, such as expenses for photocopying services and SAP system, water analysis services, procurement of water system equipment, sale of water system products, medical services, and office and warehouse rental, etc., will continue to occur in the future. The Company will ensure that prices and payment terms are in accordance with normal commercial terms.

Contents